Form 4 Filing for Akebia Therapeutics, Inc.

This filing details a Form 4 submission for Akebia Therapeutics, Inc. (AKBA), reporting ownership changes for Philip J. Vickers, a director. On April 1, 2026, Vickers was granted 214,400 Stock Options with a purchase price of $0.00, exercisable for Common Stock. These options vest over three years, with 33 1/3% vesting on the first anniversary of the grant date and the remainder vesting ratably each quarter thereafter, contingent upon continued service. The option has an expiration date of April 1, 2036, and an exercise price of $1.41. The filing also notes that the options were granted under the 2023 Plan as part of the Fifth Amended and Restated Non-Employee Director Compensation Program.